Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi

IMPORTANCE: Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the effectiveness of direct oral anticoagulants (DOACs) for this i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA Cardiol
Prif Awduron: Robinson, Austin A., Trankle, Cory R., Eubanks, Grayson, Schumann, Christopher, Thompson, Paul, Wallace, Ryan L., Gottiparthi, Shouri, Ruth, Benjamin, Kramer, Christopher M., Salerno, Michael, Bilchick, Kenneth C., Deen, Cody, Kontos, Michael C., Dent, John
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2020
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7177639/
https://ncbi.nlm.nih.gov/pubmed/32320043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.0652
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg